Clinical Pearls
Short teaching points and timely clinical notes from the rxbrief publisher desk.
Latest Pearls
3 active
Clinical PearlConfirm the indication before comparing GLP-1 agents
Before comparing semaglutide, tirzepatide, and other incretin therapies, confirm the actual indication, route, dose history, contraindications, and counseling priorities. A weight-loss conversation and a diabetes optimization conversation can require different safety checks.
Clinical PearlRenal dose checks should happen before the refill feels routine
For medications with renal dosing changes, a stable refill history does not remove the need to check the newest kidney function, recent acute illness, and interacting medications. The safest intervention often happens before the patient reports a problem.
Clinical PearlAsk about access before assuming nonadherence
When a patient misses therapy, separate intentional nonadherence from access barriers. Cost, transportation, stock issues, prior authorization delays, and health literacy can all look like refusal unless the team asks directly.